{"id":1023,"date":"2025-09-05T10:53:23","date_gmt":"2025-09-05T13:53:23","guid":{"rendered":"https:\/\/www.kachi.com.br\/?p=1023"},"modified":"2025-09-05T10:53:23","modified_gmt":"2025-09-05T13:53:23","slug":"data-era-to-decision-making-era-pharma","status":"publish","type":"post","link":"https:\/\/www.kachi.com.br\/en\/data-era-to-decision-making-era-pharma\/","title":{"rendered":"The Data Era Is Shifting to the Decision-Making Era: What This Means for Pharma Marketing"},"content":{"rendered":"

Introduction<\/strong><\/p>\n

For more than two decades, the pharmaceutical industry has invested heavily in the collection and management of scientific and commercial data. From clinical trial registries to real-world evidence platforms, the sector has built vast repositories of information. However, the growing complexity of healthcare markets, regulatory environments, and therapeutic innovation is pushing companies to evolve: the emphasis is no longer only on data generation but on decision-making. In this emerging paradigm, scientific communication plays a pivotal role, transforming static information into <\/span>actionable insights for healthcare professionals (HCPs) and patients<\/b>.<\/span>1<\/span><\/a><\/p>\n

\"\"<\/p>\n

From Data Abundance to Decision Urgency<\/strong><\/p>\n

The volume of biomedical data has expanded exponentially, with PubMed alone indexing more than one million new articles annually.2<\/sup><\/a> While this explosion of knowledge represents progress, it also creates cognitive and operational overload. Healthcare professionals need timely, relevant, and contextualized information to guide treatment choices. Pharmaceutical companies, in turn, must transform data into narratives that enable decisions<\/strong>.<\/p>\n

Real-time data use, supported by artificial intelligence (AI), is shortening the feedback loop from weeks to hours, enabling commercial and scientific teams to adjust strategies instantly. This marks a shift from a passive era of \u201cdata storage\u201d to an active era of \u201cdecision execution\u201d<\/strong>.1<\/sup><\/a><\/p>\n

<\/h3>\n

Foundations of the Decision-Making Era<\/strong><\/h3>\n

Big Data is one of the factors that has accelerated this transition. Initially described by the \u201c3 Vs\u201d \u2014 Volume, Variety, and Velocity<\/strong> \u2014 the concept has now expanded to encompass seven Vs<\/strong>:3<\/sup><\/a><\/p>\n

    \n
  1. Volume<\/li>\n
  2. Variety<\/li>\n
  3. Velocity<\/li>\n
  4. Veracity<\/li>\n
  5. Visualization<\/li>\n
  6. Variability<\/li>\n
  7. Value<\/li>\n<\/ol>\n

     <\/p>\n

    These dimensions underline not only the scale and diversity of data but also the challenges of ensuring its reliability, interpretability, and actionable relevance.4,5<\/sup><\/a><\/p>\n

    Business analytics further demonstrates how raw data can be transformed into decisions across three analytical levels:6<\/sup><\/a><\/p>\n